Researchers use real-world data in the United States to evaluate the protective role of semaglutide against Alzherimer’s ...

CHARLOTTE ( QUEEN CITY NEWS) — For Rosemarie Marshall, Alzheimer’s is unfortunately part of her family history. As she says, ...

The Alzheimer's Association is hosting the Walk to End Alzheimer’s in Tyler Saturday at UT Tyler Patriot Plaza starting at ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

With more than 55 million people worldwide living with dementia, the need for innovative support systems has never been more ...

In 1888, bacteriologists Emile Roux and Alexandre Yersin demonstrated that diphtheria occurs when bacteria release a toxin ...

The 80-year-old woman was struck by a vehicle while in the middle of a lane on Deltona Boulevard, Volusia County deputies ...

On average, patients with Alzheimer disease and related dementias spend $1199.70 per year on out-of-pocket prescription drug costs.

Semaglutide, the active ingredient in Ozempic and Wegovy, may lower the risk of Alzheimer’s disease.A new study suggests type 2 diabetes patients taking semaglu ...

Residents of the Merrill Gardens senior living community in Carolina Park banded together on Oct. 24 to support the fight ...

Caregiving from afar is getting easier with smartphones, tablets, cameras and apps — but there’s still a long way to go.

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...